Invest in ME Research Biomedical Research Colloquiums

The Invest in ME Research Biomedical Research into ME (BRMEC) Colloquiums are research meetings organised by the charity to encourage biomedical research into ME and international collaboration amongst researchers.
This has been one of the main objectives of the charity.


Invest in ME Research began arranging biomedical research conferences in our first year and have continued them ever since - mostly funded by the charity but with help from some wonderful supporters and some good friends.

The Invest in ME Research International Biomedical Research into ME Colloquiums began in 2011 as a way of bringing together researchers from around the world in a round-table discussion of ME research and ideas.
Over the years this has broadened into sharing of experiences, data and plans for future research and international collaboration.
A culmination of much of this effort was the initiation of The European ME Research Group (EMERG) concept which formed in October 2015 in London in an attempt to set up a strategy of European collaboration in ME research.

We are building a basis for creating a strategy of high-quality international biomedical research - something which has been lacking in the past decades.
This will hold great promise of finding funding opportunities and raising awareness of biomedical research into ME.

Our aim with the annual CPD-accredited research colloquiums has also been to introduce new researchers into the field of ME research, to gain new insights into the disease and enhance the strategy of research we are building.

We augment this in 2018 with the Thinking the Future meeting to build a network of young and early career researchers interested in or already performing biomedical research into ME.

The Invest in ME Research Colloquiums have spawned a number of positive initiatives over the years and are the most successful research meetings for forming new research initiatives for ME with multiple collaborative initiatives being formed across continents.


Participation in BRMEC* Events

If you are a researcher and are interested in attending the BRMEC* Colloquiums then please use our contact form to discuss this.
The aim with the IiMER Biomedical Research Colloquiums is to form progressive collaborations between trusted biomedical researchers that will augment the charity's strategy of facilitating research and lead to increased understanding of this disease and the development of treatments for it.

Contact Us


Biomedical Research into ME Colloquium 8 - 30th - 31st May 2018

BRMEC8


IIMER BRMEC8 Research Meeting London, 2018

30 - 31st May 2018

The Invest in ME Research Biomedical Research into ME Colloquium 8 (BRMEC8) will take place in London over two days from 30th - 31st May 2018.

The eighth Colloquium aims to increase international collaboration in research into ME.

We have representation from most of the main biomedical research initiatives now occurring throughout the world and also participation fron USA's Centers for Disease Control (CDC) and National Institutes of Health (NIH).

The research Colloquium in London will precede the IIMEC13 annual public international biomedical research conference on 1st June 2018.

BRMEC8 AGENDA

Click below to expand and show each day of the Colloquium

Agenda for BRMEC8 - Day 1


The agenda for the Day 1 programme on 30th May 2018


Event Presenter(s)
08:30 Arrival Refreshments
Welcome to the 8th Invest in ME International Biomedical Research into ME Colloquium Dr Ian Gibson, UEA, UK
Clinical Research
CDC Multisite study and future plans Dr Elizabeth R. Unger, CDC, USA
NIH Common Data Elements Dr Vicky Whittemore, NIH, USA
Challenges in study design and identification of patients with post-infectious ME Dr Avindra Nath, NIH, USA
From phenotype to endotype: empirical and data-driven approaches for parsing clinical heterogeneity of ME using immune signatures, proteomics and metabolomics Associate Professor Mady Hornig, Columbia University, USA
Chaired Discussion - Clinical Research Professor Angela Vincent, University of Oxford, UK
Clinical Trials
Clinical trial Results: Rituximab Dr Øystein Fluge, Bergen, Norway
Neuronal antibodies in Norwegian ME cohort Angela Vincent, Oxford University, UK
Clinical trial Results: CycloME Dr Ingrid G. Rekeland, Bergen, Norway
Chaired Discussion - Clinical Trials and Research Amolak Bansal, Epsom and St.Helier NHS Trust, UK
Microbiome
Double-blinded, placebo-controlled clinical Trial: faecal microbiota transplantation Dr Rasmus Gol /Dr Peter Johnsen, Universit of Tromso, Norway
Virome and gut microbiota research at QIB Fiona Newberry/Katharine Seton, Quadram Institute Bioscience, UK
Chaired Discussion - Microbiome Professor Maureen Hanson, Cornell University, USA
Purinergic Signalling / Metabolomics
Extracellular ATP and its role as a neurotransmitter and in regulating inflammatory responses Dr Samuel Fountain, UEA, UK
Biobank Metabolomics Data Dr Øystein Fluge, Bergen, Norway
How UK Biobank can facilitate research into ME Naomi Allen, UK Biobank / University of Oxford, UK
Cellular energetics Professor Karl Johan Tronstad, Bergen, Norway
Metabolism in ME/CFS Professor Maureen Hanson, Cornell University, USA
Stanford Metabolomics/ME Update Professor Ron Davis, Stanford, USA
How important are the associated metabolic changes in ME/CFS in driving the illness? Dr Karl Morten, University of Oxford, UK
Chaired Discussion - Purinergic Signalling / Metabolomics Professor Jonas Bergquist, Uppsala, Sweden


The schedule is subject to change

#BRMEC8 Day 1 is followed by a researchers' dinner organised by IiMER where more discussions are able to be carried out between researchers.

Agenda for BRMEC8 - Day 2


The agenda for the Day 2 programme on 31st May 2018


Event Presenter(s)
08:30 Arrival Refreshments
Welcome to the 8th Invest in ME International Biomedical Research into ME Colloquium Dr Ian Gibson, UEA, UK
Virology
The role of enteroviruses in T1 diabetes Professor Heikki Hyöty, University of Tampere, Finland
HPV and autoimmunity Dr Jesper Mehlsen, Copenhagen, Denmark
Chaired Discussion - Virology Professor Tom Wileman, University of East Anglia, UK
Immunology
Mast cells and ME Professor Theoharis Theoharides, Tufts University, USA
T cell homeostasis Dr Ben Seddon, UCL, London, UK
Oxidative stress hypothesis for reprogramming PBMC to iPSCs then to Neurons in ME/CFS patients Malav Trivedi, Nova Southeastern University, USA
Chaired Discussion - Immunology Anne Cooke, University of Cambridge, UK
Systems Biology
Integrated systems biology to understand the role of the gut microbiome in health and disease Lesley Hoyles, Imperial College London, UK
Using machine learning to objectively define ME/CFS subtypes Travis Craddock, Nova Southeastern University, USA
Chaired Discussion - Systems Biology Professor Jonas Bergquist, University of Uppsala, Sweden
ANS
Observations in Paediatric ME Professor Kristian Sommerfelt, Bergen, Norway
Relationship between sleep quality and functioning of the autonomic nervous system in ME/CFS Markku Partinen, University of Helsinki, Finland
Chaired Discussion - ANS Amolak Bansal, Epsom and St.Helier NHS Trust, UK
Biomarkers
Emerging TRP pathology: the way forward in pharmacotherapeutics and treatment Don Staines, NCNED, Australia
Immunogenetic studies in ME Asgeir Lande, Oslo, Norway
Proteomics, steroids and autoantibodies Jonas Bergquist, Uppsala, Sweden
Dolorimetry, cerebrospinal fluid miRNA, proteomics, metabolomics data James Baraniuk, Georgetown University, USA
Analysis of miRNA comparing PBMCs and exosomes profiles Elisa Oltra, Universidad Católica de Valencia “San Vicente Mártir”, Spain
Chaired Discussion - Biomarkers Professor Jonas Bergquist, Uppsala, Sweden
Summary Professor Jonas Blomberg, Uppsala, Sweden


The schedule is subject to change

#BRMEC8 Day 2 is followed by the #IIMEC13 International ME Conference 2018 Pre-Conference Dinner

The BRMEC8 Colloquium was preceded by a new event - Thinking the Future - the Young/Early Career Researchers Symposium -

London, 29th May 2018

Biomedical Research into ME Colloquium 7 - 31st May - 1st June 2017

BRMEC7


IIMER BRMEC7 Research Meeting London, 2017

31st May - 1st June 2017

The Biomedical Research into ME Colloquium 7 (BRMEC7) took place in London over two days from 31st - 1nd June 2017.

This was the seventh Invest in ME Research Colloquium and the objective was to increase international collaboration in research into ME.

Chairing and participating in the meeting were members of the Invest in ME Research Advisory Board and the newly formed European ME Research Group (EMERG).

We had representation from most of the main biomedical research initiatives occurring throughout the world as well asparticipation from the USA by the CDC and NIH.

The research Colloquium in London preceded the IIMEC12 international biomedical research conference on 2nd June 2017.

BRMEC7 AGENDA

Click below to expand and show each day of the Colloquium
BRMEC7 - Day 1
Welcome to the 7th Invest in ME Research International Biomedical Research into ME Colloquium 7 2017 Dr Ian Gibson, UEA, UK
NIH Research into ME - Status Update and Plans Dr Vicky Whittemore, NIH, USA
CDC Multisite study and future plans Dr. Elizabeth Unger, CDC, USA
Data Collection (including the following)
Modelling Professor Nancy Klimas, Fort Lauderdale, USA
Long-term follow up: Experience and lessons for ME from Norfolk Arthritis Registry Project (NOAR) Professor Alex MacGregor, Norwich, UK
Discussion
Immunology (including the following)
Dysregulation of Transient Receptor Potential (TRP) ion channels and calcium in natural killer cells in CFS/ME patients’ Professor Sonya Marshall-Gradisnik, NCNED, Australia
Professor Don Staines, NCNED, Australia
Update on B-cell research and future plans at UCL Dr Jo Cambridge, London, UK
Fane Mensah, London, UK
Studies of NK cells and cytotoxic T-cells in ME-patients from one Swedish and one Norwegian cohort Dr Jakob Theorell, Stockholm, Sweden
EBV and lymphoma Professor Michelle West, Sussex, UK
Discussion
Metabolomics (including the following)
Stanford Update Professor Ron Davis, Stanford Genome Institute, USA
Cornell Update Professor Maureen Hanson, New York, USA
Australian Update Dr Chris Armstrong, Melbourne, Australia
Overview of metabolism studies at Haukeland Professor Karl Johan Tronstad, Bergen, Norway
Discussion
Neuroimaging (including the following)
ME imaging review and ongoing study Dr Per Julin, Stockholm, Sweden
Discussion

BRMEC7 - Day 2
Opening 7th Invest in ME Research International Biomedical Research into ME Colloquium 7 2017 - Day 2 Dr Ian Gibson, UEA, UK
Clinical Trials (including the following)
LDN in ME/CFS: data on safety and efficacy Dr Olli Polo, Tampere, Finland
RituxME and CycloME clinical trials Professor Olav Mella, Bergen, Norway
Impaired glucose metabolism and PDH in ME/CFS? Dr. Øystein Fluge, Bergen, Norway
B-vitamins in ME/CFS Dr. Ingrid G. Rekeland, Bergen, Norway
Immunadsorbtion trial Professor Carmen Scheibenbogen, Berlin, Germany
Discussion
Microbiome (including the following)
IFR/UEA update Professor Simon Carding, Norwich, UK
Alterations in the enteric bacterial and viral microbiome in ME/CFS Professor Ludovic Giloteaux, New York, USA
Columbia update Associate Professor Mady Hornig, New York, USA
Discussion
Biomarkers (including the following)
miRNA in CSF Professor James Baraniuk, Washington DC, USA
Epigenetic changes in ME/CFS Dr Lubov Nathanson, Fort Lauderdale, USA
Genetic and functional genetic studies in ME / HLA and ME Dr Asgeir Lande , Oslo, Norway
Professor Ola Didrik Saugstad , Oslo, Norway
Tbc Professor Warren Tate, Otago, New Zealand
Lactate during exercise in ME/CFS Dr Katarina Lien, Oslo, Norway
Discussion
Colloquium Summary